Article

Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res

Harbor-UCLA Research and Education Institute, University of California at Los Angeles School of Medicine, Torrance 90502, USA.
Cancer Research (Impact Factor: 9.28). 04/2000; 60(5):1183-5.
Source: PubMed

ABSTRACT The invasive transformation of A-459 lung epithelial carcinoma cells has been linked to the autocrine regulation of malignant phenotypic changes by transforming growth factor beta (TGF-beta). Here we demonstrate, using stable 13C glucose isotopes, that the transformed phenotype is characterized by decreased CO2 production via direct glucose oxidation but increased nucleic acid ribose synthesis through the nonoxidative reactions of the pentose cycle. Increased nucleic acid synthesis through the nonoxidative pentose cycle imparts the metabolic adaptation of nontransformed cells to the invasive phenotype that potentially explains the fundamental metabolic disturbance in tumor cells: highly increased nucleic acid synthesis despite hypoxia and decreased glucose oxidation.

Download full-text

Full-text

Available from: Marta Cascante, Aug 25, 2015
1 Follower
 · 
77 Views
  • Source
    • "Stem cells and cancer cells have a high anabolic requirement. In these cells, PPP can be activated by growth signaling pathways such as TGF b (Boros et al. 2000). Since thiamine is a cofactor for transketolase/transaldolase enzyme, thiamine deficiency either because of genetic transport defect as in The Warburg effect 793 thiamine response megaloblastic anemia (TRMA) (Boros et al. 2003) or anti-thiamine treatment with oxythiamine, retards cell growth which can be rescued with thiamine supplementation (Rais et al. 1999; Comin-Anduix et al. 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer metabolism is characterized by increased macromolecular syntheses through coordinated increases in energy and substrate metabolism. The observation that cancer cells produce lactate in an environment of oxygen sufficiency (aerobic glycolysis) is a central theme of cancer metabolism known as the Warburg effect. Aerobic glycolysis in cancer metabolism is accompanied by increased pentose cycle and anaplerotic activities producing energy and substrates for macromolecular synthesis. How these processes are coordinated is poorly understood. Recent advances have focused on molecular regulation of cancer metabolism by oncogenes and tumor suppressor genes which regulate numerous enzymatic steps of central glucose metabolism. In the past decade, new insights in cancer metabolism have emerged through the application of stable isotopes particularly from 13C carbon tracing. Such studies have provided new evidence for system-wide changes in cancer metabolism in response to chemotherapy. Interestingly, experiments using metabolic inhibitors on individual biochemical pathways all demonstrate similar system-wide effects on cancer metabolism as in targeted therapies. Since biochemical reactions in the Warburg effect place competing demands on available precursors, high energy phosphates and reducing equivalents, the cancer metabolic system must fulfill the condition of balance of flux (homeostasis). In this review, the functions of the pentose cycle and of the tricarboxylic acid (TCA) cycle in cancer metabolism are analyzed from the balance of flux point of view. Anticancer treatments that target molecular signaling pathways or inhibit metabolism alter the invasive or proliferative behavior of the cancer cells by their effects on the balance of flux (homeostasis) of the cancer metabolic phenotype.
    Metabolomics 01/2014; 11(4):1-10. DOI:10.1007/s11306-014-0760-9 · 3.97 Impact Factor
  • Source
    • "These parameters of oxidative and non-oxidative pathways have been used previously to distinguish metabolic phenotype differences in cells in tissue culture. The distribution of oxidative and non-oxidative pathways in ribose synthesis has been applied in the investigation of thiamine responsive megalobastic anemia [50], effect of genistein in a pancreatic cancer cell line, effect of tranfection of specific mutation of ras oncogene in fibroblasts [51] and the effect of TGF beta on a lung cancer cell line [52]. The use of mass isotopomer data in characterizing metabolic phenotypes has been discussed in previous reviews [16] [17] [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tracer-based metabolomics is a systems biology tool that combines advances in tracer methodology for physiological studies, high throughput "-omics" technologies and constraint based modeling of metabolic networks. It is different from the commonly known metabolomics or metabonomics in that it is a targeted approach based on a metabolic network model in cells. Because of its complexity, it is the least understood among the various "-omics." In this review, the development of concepts and practices of tracer-based metabolomics is traced from the early application of radioactive isotopes in metabolic studies to the recent application of stable isotopes and isotopomer analysis using mass spectrometry; and from the modeling of biochemical reactions using flux analysis to the recent theoretical formulation of the constraint based modeling. How these newer experimental methods and concepts of constraint-based modeling approaches can be applied to metabolic studies is illustrated by examples of studies in determining metabolic responses of cells to pharmacological agents and nutrient environment changes.
    Clinical biochemistry 11/2010; 43(16-17):1269-77. DOI:10.1016/j.clinbiochem.2010.07.027 · 2.28 Impact Factor
  • Source
    • " Furman et al . , 1992 ) . Estradiol also directly regulates the expression glucose - 6 - phosphate dehydrogenase ( G6PDH ; Thomas et al . , 1990 ) , the enzyme that directs glucose carbons into the pentose phosphate pathway . Several enzymes in the metabolic pathways stimulated by estradiol have been proposed as targets for anti - cancer agents ( Boros et al . , 2000 ) , including transketolase ( Cascante et al . , 2002 ) , G6PDH ( Boren et al . , 2002 ) and glutaminase ( Lobo et al . , 2000 ; Medina , 2001 ; Medina et al . , 1992 ) . For example , somatostatin , dehydroepiandrosterone - sulfate , and oxythiamine , which are inhibitors of G6PDH and transketolase , and antisense glutaminase mRNA have"
    [Show abstract] [Hide abstract]
    ABSTRACT: Selective estrogen receptor (ER) modulators are highly successful breast cancer therapies, but they are not effective in patients with ER negative and selective estrogen receptor modulator (SERM)-resistant tumors. Understanding the mechanisms of estrogen-stimulated proliferation may provide a route to design estrogen-independent therapies that would be effective in these patients. In this study, metabolic flux analysis was used to determine the intracellular fluxes that are significantly affected by estradiol stimulation in MCF-7 breast cancer cells. Intracellular fluxes were calculated from nuclear magnetic resonance (NMR)-generated isotope enrichment data and extracellular metabolite fluxes, using a specific flux analysis algorithm. The metabolic pathway model used by the algorithm includes glycolysis, the tricarboxylic acid cycle (TCA cycle), the pentose phosphate pathway, glutamine catabolism, pyruvate carboxylase, and malic enzyme. The pathway model also incorporates mitochondrial compartmentalization and reversible trans-mitochondrial membrane reactions to more accurately describe the role of mitochondria in cancer cell proliferation. Flux results indicate that estradiol significantly increases carbon flow through the pentose phosphate pathway and increases glutamine consumption. In addition, intra-mitochondrial malic enzyme was found to be inactive and the malate-aspartate shuttle (MAS) was only minimally active. The inactivity of these enzymes indicates that glutamine is not oxidized within mitochondria, but is consumed primarily to provide biosynthetic precursors. The excretion of glutamine carbons from the mitochondria has the secondary effect of limiting nicotinamide adenine dinucleotide (NADH) recycle, resulting in NADH buildup in the cytosol and the excretion of lactate. The observed dependence of breast cancer cells on pentose phosphate pathway activity and glutamine consumption for estradiol-stimulated biosynthesis suggests that these pathways may be targets for estrogen-independent breast cancer therapies.
    Metabolic Engineering 12/2006; 8(6):639-52. DOI:10.1016/j.ymben.2006.06.005 · 8.26 Impact Factor
Show more